Creation of a panel of vectors based on ape adenovirus isolates

Journal of Gene Medicine

Volumn 13, Issue 1, 2011, Pages 17-25

  Roy, Soumitra ^a   Medina Jaszek, Angelica ^a   Wilson, Matthew J ^a   Sandhu, Arbansjit ^a   Calcedo, Roberto ^a   Lin, Jianping ^a   Wilson, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenovirus; Chimpanzee; Gene therapy; Vector

Indexed keywords

ADENOVIRUS VECTOR; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADENOVIRUS; APE; ARTICLE; CELL STRAIN HEK293; CHIMPANZEE; GENETIC TRANSFECTION; GENOME; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PLASMID; PRIORITY JOURNAL; SEROTYPE; VIRUS PARTICLE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; GENETIC VECTORS; HEK293 CELLS; HOMINIDAE; HUMANS; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PLASMIDS; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TRANSFECTION; TRANSGENES; VIRAL VACCINES;

ADENOVIRIDAE; PAN;

EID: 78751679255     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1530     Document Type: Article

References (15)

1. Vogels R, Zuijdgeest D, van Rijnsoever R, et al. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J Virol 2003; 77: 8263-8271.
2. Shenk T. Group C adenoviruses as vectors for gene therapy. In Viral Vectors: Gene Therapy and Neuroscience Applications, Kaplitt MG, Lowey A. D (eds). Academic Press: San Diego, 1995; 43-54.
3. Kostense S, Koudstaal W, Sprangers M, et al. Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector. AIDS 2004; 18: 1213-1216.
4. Kremer EJ, Boutin S, Chillon M, et al. Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol 2000; 74: 505-512.
5. Mittal SK, Middleton DM, Tikoo SK, et al. Pathogenesis and immunogenicity of bovine adenovirus type 3 in cotton rats (Sigmodon hispidus). Virology 1995; 213: 131-139.
6. Xu ZZ, Hyatt A, Boyle DB, et al. Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences. Virology 1997; 230: 62-71.
7. Farina SF, Gao GP, Xiang ZQ, et al. Replication-defective vector based on a chimpanzee adenovirus. J Virol 2001; 75: 11603-11613.
8. Roy S, Gao G, Lu Y, et al. Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors. Hum Gene Ther 2004; 15: 519-530.
9. Roy S, Zhi Y, Kobinger GP, et al. Generation of an adenoviral vaccine vector based on simian adenovirus 21. J Gen Virol 2006; 87: 2477-2485.
10. Roy S, Clawson DS, Lavrukhin O, et al. Rescue of chimeric adenoviral vectors to expand the serotype repertoire. J Virol Methods 2007; 141: 14-21.
11. Roy S, Vandenberghe LH, Kryazhimskiy S, et al. Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates. PLoS Pathog 2009; 5: e1000503.
12. Calcedo R, Vandenberghe LH, Roy S, et al. Host immune responses to chronic adenovirus infections in human and nonhuman primates. J Virol 2009; 83: 2623-2631.
13. Roy S, Kobinger GP, Lin J, et al. Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein. Vaccine 2007; 25: 6845-6851.
14. Rowe WP, Hartley JW, Huebner RJ Additional serotypes of the APC virus group. Proc Soc Exp Biol Med 1956; 91: 260-262.
15. Basnight M Jr, Rogers NG, Gibbs CJ Jr, et al. Characterization of four new adenovirus serotypes isolated from chimpanzee tissue explants. Am J Epidemiol 1971; 94: 166-171.